Scientists have identified a hidden molecular “switch” inside the body that turns on a secondary fat-burning system. While this discovery was made in mice, it could one day help doctors develop new treatments for bone diseases and metabolic conditions.

Researchers from McGill University in Montreal have found a specific trigger that activates an alternative energy-burning process in brown fat. Their study, published in the journal Nature, explains how this system works and why it matters for human health.

This finding is important because it reveals a previously unknown way the body produces heat and burns energy. For millions of people struggling with obesity, weak bones, or metabolic disorders, this research could eventually lead to new therapies that target these issues at a molecular level.

What Is Brown Fat and Why Does It Matter?

Most people think of body fat as something unwanted. But not all fat is created equal. The human body contains two main types of fat cells: white fat and brown fat.

White fat is the kind that stores extra energy from the food you eat. When you consume more calories than you burn, white fat expands. This is the fat most people associate with weight gain.

Brown fat, on the other hand, acts more like a furnace. It burns calories to generate heat. This process, called thermogenesis, helps keep the body warm when temperatures drop. Babies have a lot of brown fat to help them regulate their body temperature. Adults still have small amounts of brown fat, mainly around the neck, shoulders, and spine.

Scientists have known for decades that brown fat uses a specific biological pathway to produce heat. But in recent years, researchers discovered a second, alternative pathway that also helps brown fat burn energy. Until now, no one knew what activated this backup system.

The Discovery: How the ‘Switch’ Works

Led by Dr. Lawrence Kazak at McGill University’s Rosalind and Morris Goodman Cancer Institute, the research team identified the exact molecular trigger for this alternative system. They call it the futile creatine cycle.

Here is how it works, in simple terms:

• When the body is exposed to cold temperatures, it starts breaking down stored fat to create heat.
• This process releases a molecule called glycerol, which is a byproduct of fat metabolism.
• The glycerol then binds to an enzyme called TNAP at a specific location the researchers call the “glycerol pocket.”
• This interaction activates the alternative heat-producing pathway in brown fat cells.

“This is the first time we’ve identified how an alternative heat-producing pathway is activated, independent of the classic system,” said Dr. Kazak, who is an Associate Professor in the Department of Biochemistry and the Canada Research Chair in Adipocyte Biology. “That opens the door to understanding how multiple energy-burning systems work together to keep the body warm at the just-right temperature.”

Why This Matters for Bone Health

While brown fat research often focuses on metabolism and obesity, the most immediate impact of this discovery may actually be for bone health. This is because the TNAP enzyme plays a critical role in bone formation.

The TNAP enzyme is essential for calcification, which is the process that builds and maintains strong bones. Without enough TNAP activity, bones cannot harden properly. This can lead to serious health problems.

Mutations that reduce TNAP activity cause a rare disorder called hypophosphatasia. People with this condition often have what is sometimes called “soft bones.” Symptoms can include:

• Frequent fractures
• Chronic bone pain
• Skeletal abnormalities
• Difficulty walking or moving

Certain inherited mutations have made this disorder more common in parts of Canada, including Quebec and Manitoba. For families affected by hypophosphatasia, this new research offers hope for better treatments.

How the Same Switch Affects Bones and Fat

The researchers discovered something surprising. The same molecular switch that activates energy burning in brown fat cells also affects the cells responsible for bone mineralization. This means the TNAP enzyme serves a dual purpose in the body.

By studying TNAP mutations in laboratory experiments, the scientists found that the glycerol-binding mechanism directly influences cells that harden and strengthen bones. This connection between fat metabolism and bone health was previously unknown.

This work builds on earlier research by McGill co-author Dr. Marc McKee and co-author Dr. José-Luis Millán of the Sanford Burnham Prebys Medical Discovery Institute. Their previous efforts helped produce a first-in-class enzyme replacement therapy designed specifically for hypophosphatasia patients with defective TNAP enzymes.

What This Could Mean for Future Treatments

Dr. McKee explained the potential impact of this finding: “This finding opens the door to a new kind of treatment, where increasing the activity of the TNAP enzyme through its glycerol pocket by natural or synthetic bioactive compounds could potentially boost the beneficial actions of the enzyme in patients, to help restore deficient bone mineralization to healthy levels.”

In other words, if scientists can find a way to activate the TNAP enzyme through its glycerol pocket, they might be able to help people with weak bones build stronger skeletons. This could benefit not only those with rare genetic disorders but also older adults with osteoporosis or other bone-weakening conditions.

Researchers have already identified dozens of possible drug candidates for future investigation. These compounds could be tested to see if they safely activate the TNAP enzyme in humans.

Practical Takeaways for Readers

While this research is still in its early stages, there are some important points to keep in mind:

• This was a mouse study. The findings have not yet been tested in humans. Many discoveries that work in animals do not translate directly to human medicine.
• Brown fat is not a quick fix for weight loss. While brown fat burns calories, the amount in adults is small. You cannot rely on it to lose weight without other lifestyle changes.
• Cold exposure may activate brown fat. Some research suggests that spending time in cooler temperatures can stimulate brown fat activity. However, this is not a substitute for exercise and a healthy diet.
• Bone health requires multiple nutrients. Calcium and vitamin D remain essential for strong bones. No single enzyme or switch can replace good nutrition.
• Talk to your doctor about bone health. If you have a family history of bone disease or fractures, ask your healthcare provider about screening and prevention options.

What Experts Generally Say About This Condition and Treatment

Hypophosphatasia is a rare genetic disorder that affects about 1 in 100,000 people worldwide. However, in certain populations, including some communities in Canada, the rate is much higher. The condition ranges from mild to severe. In severe cases, it can be life-threatening, especially in infants.

Current treatment options are limited. The enzyme replacement therapy developed by Dr. McKee and Dr. Millán is one of the few targeted treatments available. It helps replace the missing or defective TNAP enzyme in patients. However, it requires regular infusions and is very expensive.

Experts in the field say that finding new ways to boost TNAP activity naturally could be a game-changer. If researchers can develop a pill or injection that activates the enzyme through its glycerol pocket, it could offer a more convenient and affordable treatment option.

Dr. Kazak and his team emphasize that more research is needed before any human treatments can be developed. The next steps include testing potential drug candidates in animal models and eventually in clinical trials with human volunteers.

The Bigger Picture

This study is part of a growing body of research on brown fat and its role in human health. Scientists around the world are exploring how to harness the power of brown fat to treat obesity, diabetes, and other metabolic disorders.

The study, titled “Glycerol-driven TNAP activation in thermogenesis and mineralization,” involved collaboration with scientists from Queen Mary University of London, Northeastern University, the Sanford Burnham Prebys Medical Discovery Institute, and the Maine Health Institute for Research.

Funding came from the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, and the Fonds de recherche du Québec — Santé.

Materials were provided by McGill University. Note: Content may be edited for style and length.

Source: ScienceDaily